Truist Financial
THC icon

Truist Financial’s Tenet Healthcare THC Stock Holding History

Truist Financial’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.5M Sell
13,388
-561
-4% -$103K ﹤0.01% 1256
2026
Q1 		$2.63M Sell
13,949
-321
-2% -$67.6K ﹤0.01% 1162
2025
Q4 		$2.84M Buy
14,270
+2,601
+22% +$526K ﹤0.01% 1101
2025
Q3 		$2.37M Buy
11,669
+1,335
+13% +$237K ﹤0.01% 1255
2025
Q2 		$1.82M Sell
10,334
-2,136
-17% -$322K ﹤0.01% 1331
2025
Q1 		$1.68M Buy
12,470
+63
+0.5% +$8.3K ﹤0.01% 1300
2024
Q4 		$1.57M Buy
12,407
+198
+2% +$29.4K ﹤0.01% 1354
2024
Q3 		$2.03M Sell
12,209
-11,966
-49% -$1.81M ﹤0.01% 1224
2024
Q2 		$3.22M Buy
24,175
+14,703
+155% +$1.77M ﹤0.01% 1056
2024
Q1 		$996K Buy
9,472
+653
+7% +$58.7K ﹤0.01% 1621
2023
Q4 		$666K Sell
8,819
-215
-2% -$13.6K ﹤0.01% 1815
2023
Q3 		$595K Sell
9,034
-682
-7% -$51K ﹤0.01% 1828
2023
Q2 		$791K Buy
9,716
+5,521
+132% +$393K ﹤0.01% 1698
2023
Q1 		$249K Buy
+4,195
New +$233K ﹤0.01% 2320
2022
Q4 		– Sell
-8,435
Closed -$435K – 2676
2022
Q3 		$435K Sell
8,435
-5,945
-41% -$353K ﹤0.01% 1907
2022
Q2 		$756K Sell
14,380
-3,704
-20% -$258K ﹤0.01% 1680
2022
Q1 		$1.55M Sell
18,084
-2,022
-10% -$166K ﹤0.01% 1405
2021
Q4 		$1.64M Buy
20,106
+1,674
+9% +$122K ﹤0.01% 1385
2021
Q3 		$1.23M Sell
18,432
-4,352
-19% -$309K ﹤0.01% 1495
2021
Q2 		$1.53M Buy
22,784
+243
+1% +$15.1K ﹤0.01% 1429
2021
Q1 		$1.17M Sell
22,541
-8,805
-28% -$445K ﹤0.01% 1489
2020
Q4 		$1.25M Buy
31,346
+9,047
+41% +$292K ﹤0.01% 1368
2020
Q3 		$546K Sell
22,299
-189
-0.8% -$4.83K ﹤0.01% 1684
2020
Q2 		$407K Buy
22,488
+155
+0.7% +$3.05K ﹤0.01% 1740
2020
Q1 		$322K Buy
22,333
+1,737
+8% +$49.9K ﹤0.01% 1812
2019
Q4 		$783K Buy
+20,596
New +$617K ﹤0.01% 1569

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Truist Financial's THC Position: Q2 2026 in Review

Truist Financial reduced its Tenet Healthcare (THC) stake by 4% in Q2 2026, selling an estimated $103K and leaving 13,388 shares worth $2.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1256.

Truist Financial first reported a position in THC in Q4 2019 and has held it in 26 quarters since. The position peaked at $3.22M in Q2 2024. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Truist Financial held 13,388 shares of Tenet Healthcare worth $2.5M as of Q2 2026.
  • Truist Financial sold 561 Tenet Healthcare shares in Q2 2026, an estimated $103K.
  • Tenet Healthcare made up ﹤0.01% of Truist Financial's portfolio in Q2 2026, its #1256 holding.
  • Truist Financial first reported a position in Tenet Healthcare in Q4 2019 and has held it in 26 quarters since.
  • Truist Financial's Tenet Healthcare position peaked at $3.22M in Q2 2024.
  • 681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.